CBYL Description — Carbylan Therapeutics Inc
Carbylan Therapeutics is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of combination therapies that address unmet medical needs. Co.'s Hydros-TA, is a combination intra-articular product, designed to provide pain relief with a single 6 ml intra-anticular injection, comprised of 52 mg of bacterially derived HA and 10 mg of TA. Relief is provided from Co.'s low dose steroid component and sustained pain relief, up to six months, is provided from its HA component. Hydros-TA is comprised of bacterially derived HA-based hydrogel particles suspended in a solution of hyaluronic acid.